SCHEMBL23838116

SCHEMBL23838116

CCCN(C)c1ccc(C(=O)N(C)C)c(Cl)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCAR3 P49019 2/20 0.44
▸ CNR1 P21554 3/20 0.40
▸ AOC3 Q16853 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ MCHR1 Q99705 1/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ HCRTR1 O43613 1/20 0.32
▸ HCRTR2 O43614 1/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ PRKAB2 O43741 1/20 0.32
▸ PRKAG1 P54619 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20077096 0.81 CNR1 (0.42) CNR1ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL20077654 0.79 CNR1 (0.39) CNR1ALDH1A1MCHR1MEN1KMT2A
SCHEMBL8828641 0.74 CNR1 (0.43) CNR1ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL5425587 0.73 EGFR (0.47) CNR1ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL18838583 0.73 CNR1 (0.43) CNR1ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL18872731 0.72 HCAR3 (0.41) HCAR3CNR1ALDH1A1MCHR1SMN1; SMN2
SCHEMBL9363634 0.72 MAPT (0.40) CNR1ALDH1A1MEN1KMT2AHCRTR1
SCHEMBL20077387 0.70 XPO1 (0.36) HCAR3CNR1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL20077101 0.69 CNR1 (0.40) HCAR3CNR1TP53ALDH1A1MEN1
SCHEMBL20060890 0.69 POLB (0.47) CNR1ALDH1A1MEN1KMT2AHCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3526203-B1 N-ARYL AND N-HETEROARYL PIPERIDINE DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS, COMPOSITIONS, AND THEIR USE MERCK SHARP & DOHME (US) 2021-09-22 — — EP disclosed
Send feedback